Insmed (MEX:INSM) Construction In Progress: MXN793 Mil (As of Mar. 2026)


MEX:INSM Insmed Inc MEX:INSM
68 GF Score
Price MXN3,760.00
GF Value MXN5,773.42
! 4 Warning Signs
View Full Analysis

What is Insmed Construction In Progress?

Insmed MEX:INSM 68 Construction In Progress is MXN793 Mil as of Mar. 2026. GuruFocus rates MEX:INSM with a GF Score™ of 68/100 and a GF Value™ of MXN5,773.42. The stock has 4 warning signs investors should review.

Insmed's quarterly construction in progress declined from Sep. 2025 (MXN841 Mil) to Dec. 2025 (MXN764 Mil) but then increased from Dec. 2025 (MXN764 Mil) to Mar. 2026 (MXN793 Mil).

Insmed's annual construction in progress increased from Dec. 2023 (MXN602 Mil) to Dec. 2024 (MXN1,066 Mil) but then declined from Dec. 2024 (MXN1,066 Mil) to Dec. 2025 (MXN764 Mil).

Insmed Construction In Progress Historical Data

* Premium members only.

The historical data trend for Insmed's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Insmed Construction In Progress Chart

Insmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 569.96 575.70 601.72 1,066.29 763.62

Insmed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 930.60 863.83 840.94 763.62 792.68
MEX:INSM
68GF Score
Insmed Inc MEX:INSM
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Insmed Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of MXN793 Mil mean?
Insmed (MEX:INSM) has a Construction In Progress of MXN793 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Insmed and its competitors.
Is Insmed's Construction In Progress too high?
Insmed's current Construction In Progress is MXN793 Mil. Overall, Insmed has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Insmed's Construction In Progress compare to INCY and BNTX?
Insmed's Construction In Progress of MXN793 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Insmed and its competitors. Insmed's current Construction In Progress is MXN793 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Insmed stock overvalued right now?
Insmed (MEX:INSM) has a current Construction In Progress of MXN793 Mil. The stock's GF Value™ is MXN5,773.42, compared to a current price of MXN3,760.00 — trading 34.9% below its estimated fair value. The current Construction In Progress is MXN793 Mil. Insmed's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Insmed (MEX:INSM), the current Construction In Progress is MXN793 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Insmed (MEX:INSM) Overvalued in 2026?

Based on GuruFocus' analysis, Insmed stock appears to be undervalued. The current stock price of MXN3,760.00 is trading 34.9% below its estimated GF Value™ of MXN5,773.42.

Key valuation signals for MEX:INSM:

  • Construction In Progress: MXN793 Mil
  • GF Value™: MXN5,773.42 vs. price of MXN3,760.00 (34.9% below fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the MEX:INSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Insmed Business Description

Address 700 US Highway 202/206, Bridgewater, NJ, USA, 08807
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
68GF Score

Get the complete analysis for MEX:INSM

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,760.00
Price
MXN5,773.42
GF Value